76 related articles for article (PubMed ID: 23072895)
1. An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction.
Jose RA; Voet A; Broos K; Jakobi AJ; Bruylants G; Egle B; Zhang KY; De Maeyer M; Deckmyn H; De Borggraeve WM
Chem Commun (Camb); 2012 Nov; 48(92):11349-51. PubMed ID: 23072895
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
3. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.
Broos K; Trekels M; Jose RA; Demeulemeester J; Vandenbulcke A; Vandeputte N; Venken T; Egle B; De Borggraeve WM; Deckmyn H; De Maeyer M
J Biol Chem; 2012 Mar; 287(12):9461-72. PubMed ID: 22232560
[TBL] [Abstract][Full Text] [Related]
4. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
[TBL] [Abstract][Full Text] [Related]
5. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
6. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
Fukuda K; Doggett T; Laurenzi IJ; Liddington RC; Diacovo TG
Nat Struct Mol Biol; 2005 Feb; 12(2):152-9. PubMed ID: 15665869
[TBL] [Abstract][Full Text] [Related]
7. [Determination of the detachment force of platelet membrane protein GPIb/IX and von Willebrand factor].
Wang Y; Gao Z; Hu Y; Hu Q; Yang C; Zhuang F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):590-4, 605. PubMed ID: 19634679
[TBL] [Abstract][Full Text] [Related]
8. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity.
Li CQ; Ye P; Cao Zf ; Wang H; Lu L; Nicastro P; Wood E; Robert JJ; Ouwehand WH; Hill F; López JA; Wardell MR
Protein Expr Purif; 2001 Jul; 22(2):200-10. PubMed ID: 11437595
[TBL] [Abstract][Full Text] [Related]
9. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
[TBL] [Abstract][Full Text] [Related]
10. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
11. Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor.
Mohri H; Yamazaki E; Suzuki Z; Takano T; Yokota S; Okubo T
Thromb Haemost; 1997 Apr; 77(4):760-6. PubMed ID: 9134656
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction.
Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF
Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet adhesion by peptidomimetics mimicking the interactive β-hairpin of glycoprotein Ibα.
Bernard E; Buckley V; Moman E; Coleman L; Meade G; Kenny D; Devocelle M
Bioorg Med Chem Lett; 2012 May; 22(9):3323-6. PubMed ID: 22460035
[TBL] [Abstract][Full Text] [Related]
14. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions.
Nishiya T; Murata M; Handa M; Ikeda Y
Biochem Biophys Res Commun; 2000 Apr; 270(3):755-60. PubMed ID: 10772897
[TBL] [Abstract][Full Text] [Related]
15. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
[TBL] [Abstract][Full Text] [Related]
16. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the initial platelet adhesion in arterial thrombosis: molecular dynamics simulations.
Li J; Zhang L; Sun Y
J Mol Graph Model; 2012 Jul; 37():49-58. PubMed ID: 22622010
[TBL] [Abstract][Full Text] [Related]
18. Binding Mechanism between Platelet Glycoprotein and Cyclic Peptide Elucidated by McMD-Based Dynamic Docking.
Bekker GJ; Oshima K; Araki M; Okuno Y; Kamiya N
J Chem Inf Model; 2024 May; 64(10):4158-4167. PubMed ID: 38751042
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationship of the A1 domain of von Willebrand factor.
Girma JP; Ribba AS; Meyer D
Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
[TBL] [Abstract][Full Text] [Related]
20. Rational design of antithrombotic peptides to target the von Willebrand factor (vWf)--GPIb integrin interaction.
Munoz Cdel C; Campbell W; Constantinescu I; Gyongyossy-Issa MI
J Mol Model; 2008 Dec; 14(12):1191-202. PubMed ID: 18923852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
